Abstract LB400: Identification of potential biomarkers and immune characteristics in patients with non-small cell lung cancer treated with CJRB-101 plus pembrolizumab
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Yonsei University, Yonsei Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409820834
